Cargando…
Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome
Interstitial cystitis (IC)/bladder pain syndrome (BPS) is a chronic bladder disease of unknown etiology characterized by urinary frequency and episodic and chronic pain. Analgesic treatments for IC/BPS are limited, especially for patients with non-Hunner (non-ulcerative) type IC who usually have poo...
Autores principales: | Brandolini, Laura, Aramini, Andrea, Bianchini, Gianluca, Ruocco, Anna, Bertini, Riccardo, Novelli, Rubina, Angelico, Patrizia, Valsecchi, Anna Elisa, Russo, Roberto, Castelli, Vanessa, Cimini, Annamaria, Allegretti, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096165/ https://www.ncbi.nlm.nih.gov/pubmed/35571079 http://dx.doi.org/10.3389/fphar.2022.854238 |
Ejemplares similares
-
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
por: Brandolini, Laura, et al.
Publicado: (2019) -
CXCR1/2 pathways in paclitaxel-induced neuropathic pain
por: Laura, Brandolini, et al.
Publicado: (2017) -
CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
por: Castelli, Vanessa, et al.
Publicado: (2021) -
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions
por: Brandolini, Laura, et al.
Publicado: (2022) -
Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice
por: Castelli, Vanessa, et al.
Publicado: (2023)